Adams GC, Devlin JE, Klontz E, Laing RA, Branda JA. Development of a Combined Clinical and Research-Developed Testing Strategy for Highly Pathogenic Avian Influenza A Virus H5. Open Forum Infect Dis. 2025 Dec 10;13(1):ofaf744
Highly pathogenic avian influenza A (H5) virus continues to spread in animals with ongoing concern for potential human transmission. We describe an adaptable H5 screening approach that integrates clinical laboratory workflows with research-developed assays. This strategy efficiently screened thousands of samples, providing a practical and scalable model for H5 surveillance.
See Also:
Latest articles in those days:
- [preprint]The mammalian-adaptive PB2-E627K substitution preserves viral fitness of clade 2.3.4.4b H5N1 HPAIV in birds 5 hours ago
- Mallard super-shedders of avian influenza exhibit distinct cloacal microbial abundance profiles 9 hours ago
- A digitally immune-optimized influenza vaccine broadly neutralizes swine and human H1N1 influenza viruses and protects from heterologous challenge 9 hours ago
- Associations between vaccine misinformation and influenza vaccine uptake: a population-based interrupted time-series study in China 10 hours ago
- Infection and transmission dynamics of bovine and human influenza A H5N1 viruses in mouse and hamster models 10 hours ago
[Go Top] [Close Window]
